Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)

Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone Fibroblast growth factor‐23 (FGF23). Anemia, elevated FGF23, and elevated serum phosphate are significant mortality risk factors for patients with chronic kidney disease (CKD). However, the contribution of anemia to overall ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Noonan, Megan L., Clinkenbeard, Erica L., Ni, Pu, Swallow, Elizabeth A., Tippen, Samantha P., Agoro, Rafiou, Allen, Matthew R., White, Kenneth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261757/
https://www.ncbi.nlm.nih.gov/pubmed/32476270
http://dx.doi.org/10.14814/phy2.14434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261757/
https://www.ncbi.nlm.nih.gov/pubmed/32476270
http://dx.doi.org/10.14814/phy2.14434

Ejemplares similares